- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01195545
Veritas Laparoscopic Paraesophageal Hiatal Hernia (PEH) Repair Pilot Trial
Veritas Laparoscopic PEH Repair Pilot Trial
This is an investigator initiated pilot study to observe the short-term outcomes (a follow-up period of up to six months) of patients who undergo a laparoscopic paraesophageal Hiatal hernia (PEH) repair using the Veritas® Collagen Matrix brand biological mesh. This is a preliminary study at the University of Washington.
A PEH occurs when the stomach protrudes through the diaphragm next to the esophagus. The chance of recurrence of a Hiatal hernia after laparoscopic PEH repair is between 20-40% within 6 months.During laparoscopic PEH repair, a mesh-type product is used as a scaffold. The mesh serves as a reinforcing material during the surgical repair. It is cut to the appropriate size needed for the hernia and sutured to the surrounding diaphragmatic tissue. There are many different types of meshes available on the market, and vary in the degree of manageability, strength, and adherence.
Although surgical meshes work on the same principal, the variance between materials may affect patient outcomes. There is evidence that a biologic mesh, specifically one derived from Small Intestinal Submucosa (SIS), decreases the short-term (6-month) recurrence rates compared to a synthetic mesh or another type of biologic mesh. A biologic mesh, serving as a scaffold, will be replaced by the patient's own tissue after about 6 months. Theoretically, this would prevent the possible complications associated with synthetic mesh including mesh erosion into the esophagus or stricture of the esophagus.
There are some case series showing similar short-term results between the different biologic meshes, but there is no direct comparative data.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
A. Subjects must have a documented symptomatic paraesophageal hernia that:
- 1. Is greater than 5 cm hiatal hernia on Upper Gastrointestinal (UGI) series
- 2. Has evidence that the stomach or other viscera is present in the hernia and does not spontaneously reduce from the mediastinum
- 3. Has significant symptoms or signs of a paraesophageal hernia: heartburn, dysphagia, chest pain, shortness of breath, post-prandial abdominal pain, early satiety, odynophagia or chronic anemia
B. Consenting adult ≥18 years ~ documentation of informed consent will be recorded in the research records
C. Must be able to participate in follow-up evaluations (subjects must be fully cognitive)
D. Has a telephone
E. Free of cognitive or speech impairment
Exclusion Criteria:
A. Previous operation of the esophagus or stomach
B. Associated gastrointestinal diseases that require extensive medical or surgical intervention that might interfere with quality of life assessment (e.g. Crohn's disease)
C. Emergent operation for acute volvulus (twisting/rotation of the bowel leading to obstruction)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Veritas Mesh in Hernia Repair
Subjects undergoing laparoscopic paraesophageal hiatal hernia repair using a bovine pericardium mesh (BP) (Veritas® Collagen Matrix, Synovis ®, St. Paul MN) as a reinforcing material during repair.
|
biological mesh in hernia repair
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recurrence Rate of Hiatal Hernia Rate Based on Upper Gastrointestinal (UGI) Series
Time Frame: 6 months post procedure
|
Number of subjects experiencing recurrence greater than 2cm as well as 5cm post surgery.
|
6 months post procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pre and Post-operative Symptoms
Time Frame: Pre-surgery and 6 month follow up
|
Heartburn frequency Pre and Post-operative was measured using the Paraesophagel Hernia Patient Questionnaire-Visual analog score (VAS). The VAS measures subjective characteristics that specify the respondents level of agreement to a statement. In this questionnaire, the patient indicated how frequent they had Heartburn. The Heartburn frequency measurement scale: 0=Never, 1=once/month,2=once/week,3=once/day,4=several/day. The lower the VAS score the better the outcome meaning less episodes of Heartburn. The Heartburn VAS score was measured pre-operative and post-operative. The comparison of Heartburn VAS score pre-operative and post-operative indicated that participants experienced Improvement and No Improvement. |
Pre-surgery and 6 month follow up
|
Pre and Post-operative Symptoms
Time Frame: Pre-surgery and 6 month follow up
|
Regurgitation frequency Pre and Post-operative was measured using the Paraesophagel Hernia Patient Questionnaire-Visual analog score (VAS). The VAS measures subjective characteristics that specify the respondents level of agreement to a statement. In this questionnaire, the patient indicated how frequent they had Regurgitation. The Regurgitation frequency measurement scale: 0=Never, 1=once/month,2=once/week,3=once/day,4=several/day. The lower the VAS score the better the outcome meaning less episodes of Regurgitation. The Regurgitation VAS score was measured pre-operative and post-operative. The comparison of Regurgitation VAS score pre-operative and post-operative indicated that participants experienced Improvement and No Improvement. |
Pre-surgery and 6 month follow up
|
Pre and Post-operative Symptoms
Time Frame: Pre-surgery and 6 month follow up
|
Dysphagia frequency Pre and Post-operative was measured using the Paraesophagel Hernia Patient Questionnaire-Visual analog score (VAS). The VAS measures subjective characteristics that specify the respondents level of agreement to a statement. In this questionnaire, the patient indicated how frequent they had Dysphagia. The Dysphagia frequency measurement scale: 0=Never, 1=once/month,2=once/week,3=once/day,4=several/day. The lower the VAS score the better the outcome meaning less episodes of Dysphagia. The Dysphagia VAS score was measured pre-operative and post-operative. The comparison of Dysphagia VAS score pre-operative and post-operative indicated that some participants experienced Improvement and others worsen. |
Pre-surgery and 6 month follow up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Brant K. Oelschlager, M.D., University of Washington
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 38048
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hiatal Hernia
-
University Hospital, BordeauxRecruiting
-
Foregut Research FoundationNot yet recruitingParaesophageal Hernia | Large Hiatal HerniaUnited States
-
University of NebraskaLifeCellCompletedHiatal Hernia | Esophageal Hernia | Hernia, Esophageal | Hernia, Paraesophageal | Paraesophageal Hiatal Hernia | Sliding Esophageal Hernia | Sliding Hiatal HerniaUnited States
-
Prof Urs ZinggEnrolling by invitationHiatal Hernia Large
-
Washington University School of MedicineMusculoskeletal Transplant FoundationCompleted
-
Oulu University HospitalCentral Finland Hospital DistrictRecruitingRecurrence | Hiatal Hernia | Hiatal Hernia, Paraesophageal | Paraesophageal HerniaFinland
-
NorthShore University HealthSystemRecruitingHiatal HerniaUnited States
-
Karolinska InstitutetCompleted
-
Miromatrix Medical Inc.Completed
-
Paracelsus Medical UniversityMedical University of Vienna; Medical University Innsbruck; Krankenhaus Barmherzige... and other collaboratorsNot yet recruiting
Clinical Trials on Veritas® Collagen Matrix
-
The Cleveland ClinicCompletedPelvic Organ Prolapse
-
Baxter Healthcare CorporationSynovis Surgical InnovationsCompleted
-
Walter Reed National Military Medical CenterUnknown
-
University of North Carolina, Chapel HillGeistlich Pharma AGCompletedTooth ExtractionUnited States
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedEvaluation of Two Types of Matrix (Mucograft® and Mucoderm®) Associated With Coronally Advanced FlapGingival RecessionBrazil
-
Universidade Federal do Rio Grande do NorteUnknownGingival Recession
-
Fibralign CorporationStanford UniversityRecruiting
-
Vastra Gotaland RegionCompleted
-
Fibralign CorporationUniversity of ChicagoRecruitingLymphedema | EdemaUnited States